Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
mental disorder
|
| gptkbp:affects |
adolescents
adults |
| gptkbp:alsoKnownAs |
social phobia
|
| gptkbp:cause |
social isolation
impaired occupational functioning reduced quality of life |
| gptkbp:characterizedBy |
avoidance of social interactions
fear of being judged intense fear of social situations |
| gptkbp:comorbidity |
gptkb:depression
substance abuse other anxiety disorders |
| gptkbp:diagnosedBy |
gptkb:DSM-5_criteria
clinical interview |
| gptkbp:DSM-5_code |
300.23
|
| gptkbp:fieldOfStudy |
psychiatry
psychology |
| gptkbp:firstDescribed |
early 20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Social Anxiety Disorder
|
| gptkbp:ICD-10_code |
F40.1
|
| gptkbp:onset |
usually in adolescence
|
| gptkbp:prevalence |
about 7% of the population
|
| gptkbp:relatedTo |
gptkb:generalized_anxiety_disorder
gptkb:panic_disorder gptkb:specific_phobia |
| gptkbp:riskFactor |
childhood shyness
family history of anxiety disorders negative social experiences |
| gptkbp:supportersGroup |
gptkb:National_Alliance_on_Mental_Illness
gptkb:Anxiety_and_Depression_Association_of_America |
| gptkbp:symptom |
nausea
blushing sweating trembling rapid heartbeat |
| gptkbp:treatment |
gptkb:selective_serotonin_reuptake_inhibitors
beta blockers cognitive behavioral therapy exposure therapy antidepressant medication |
| gptkbp:bfsParent |
gptkb:Anti-Anxiety_Agents
|
| gptkbp:bfsLayer |
7
|